Search results
Shining a Spotlight on IBS: Anatara Lifesciences Makes Strides in Phase II Trial during IBS...
Digital Journal· 13 hours agoWith 1 in 7 Australians... majority of IBS sufferers are not satisfied with their current prescription or OTC ( "over the counter") medications. Pictured - Anatara's RMH ( ...
Will Smith Begs Oscar Bosses to Let Him Back Into the Academy After 10-Year Ban for Chris Rock Slap
In Touch Weekly· 13 hours agoWill Smith has a big hit on his hands with comeback movie Bad Boys 4, which he’s hoping will win him...
AbCellera Biologics (ABCL) Upgraded to Buy: Here's What You Should Know
Zacks via Yahoo Finance Canada· 14 hours agoAbCellera Biologics (ABCL) might move higher on growing optimism about its earnings prospects, which...
Redfin (RDFN) Upgraded to Buy: Here's What You Should Know
Zacks via Yahoo Finance Canada· 14 hours agoThis upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most...
C4 Therapeutics (CCCC) Upgraded to Buy: Here's Why
Zacks via Yahoo Finance Canada· 14 hours agoThis upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. A company's...
Jack Henry (JKHY) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance Canada· 14 hours agoThis upgrade primarily reflects an upward trend in earnings estimates, which is one of the most...
What Makes Teleflex (TFX) a New Buy Stock
Zacks via Yahoo Finance Canada· 14 hours agoTeleflex (TFX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of...
Century Therapeutics (IPSC) Moves to Buy: Rationale Behind the Upgrade
Zacks via Yahoo Finance Canada· 14 hours agoCentury Therapeutics (IPSC) might move higher on growing optimism about its earnings prospects,...
Norwegian Cruise Line (NCLH) Moves to Buy: Rationale Behind the Upgrade
Zacks via Yahoo Finance Canada· 14 hours agoNorwegian Cruise Line (NCLH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism...
What Makes Curis (CRIS) a New Buy Stock
Zacks via Yahoo Finance Canada· 14 hours agoCuris (CRIS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the...
